$0.7970
At close: Jun 4, 6:13 PM EDT
$0.8000
0.003000.38%
After Hours: 6:13 PM EDT
Comments
Loading...
Coherus Oncology Earnings Estimates, EPS & Revenue | NASDAQ:CHRS | Benzinga
Coherus Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS
$-0.350
Quarterly Revenue
$7.60M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$272.25M
Analyze the earnings history of Coherus Oncology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus BioSciences | -$0.14 | — | — | — | $64.98M | — | — | — | 08/07/2025 | Get Alert |
| CHRS | Coherus BioSciences | -$0.48 | -$0.13 | -$0.35 | -169.23% | $2.31M | — | $7.60M | — | 05/12/2025 | Get Alert |
| CHRS | Coherus BioSciences | -$0.62 | -$0.13 | -$0.28 | -115.38% | $91.52M | $43.88M | $54.14M | 23.39% | 03/10/2025 | Get Alert |
| CHRS | Coherus BioSciences | -$0.27 | -$0.12 | -$0.01 | 91.67% | $74.57M | $59.23M | $70.77M | 19.49% | 11/06/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.38 | -$0.16 | -$0.14 | 12.50% | $58.72M | $64.16M | $64.98M | 1.28% | 08/08/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.75 | -$0.24 | -$0.32 | -33.33% | $32.44M | $80.25M | $77.06M | -3.97% | 05/09/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | 03/13/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | 11/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | 08/02/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | 05/08/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | 03/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | 11/08/2022 | Get Alert |
| CHRS | Coherus BioSciences | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | 08/04/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | 05/05/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | 02/17/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | 11/08/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | 08/05/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | 05/06/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | 02/24/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | 11/05/2020 | Get Alert |
| CHRS | Coherus BioSciences | $0.32 | $0.33 | $0.81 | 145.45% | $83.43M | $104.95M | $135.67M | 29.27% | 08/06/2020 | Get Alert |
Coherus Oncology (CHRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.35 | $-0.13 | -169.2 % |
| Q4 | 2025-03-10 | $-0.28 | $-0.13 | -115.4 % |
| Q3 | 2024-11-06 | $-0.01 | $-0.12 | 91.7 % |
| Q2 | 2024-08-08 | $-0.14 | $-0.16 | 12.5 % |
Coherus Oncology (CHRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $54.14M | $43.88M | 23.4 % |
| Q3 | 2024-11-06 | $70.77M | $59.23M | 19.5 % |
| Q2 | 2024-08-08 | $64.98M | $64.16M | 1.28 % |
| Q1 | 2024-05-09 | $77.06M | $80.25M | -3.97 % |
FAQ
When is Coherus Oncology (NASDAQ:CHRS) reporting earnings?
Coherus Oncology (CHRS) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Coherus Oncology (NASDAQ:CHRS)?
The Actual EPS was $-0.35, which missed the estimate of $-0.13.
What were Coherus Oncology’s (NASDAQ:CHRS) revenues?
The Actual Revenue was $7.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
